TScan Therapeutics Inc (TCRX)
7.76
-0.02
(-0.26%)
USD |
NASDAQ |
May 10, 12:00
TScan Therapeutics Market Cap: 410.22M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 411.27M |
| May 08, 2024 | 423.43M |
| May 07, 2024 | 458.32M |
| May 06, 2024 | 465.72M |
| May 03, 2024 | 452.51M |
| May 02, 2024 | 457.26M |
| May 01, 2024 | 455.68M |
| April 30, 2024 | 408.10M |
| April 29, 2024 | 405.99M |
| April 26, 2024 | 386.96M |
| April 25, 2024 | 385.37M |
| April 24, 2024 | 390.13M |
| April 23, 2024 | 365.74M |
| April 22, 2024 | 358.69M |
| April 19, 2024 | 343.57M |
| April 18, 2024 | 331.50M |
| April 17, 2024 | 323.36M |
| April 16, 2024 | 341.56M |
| April 15, 2024 | 368.39M |
| April 12, 2024 | 371.26M |
| April 11, 2024 | 373.66M |
| April 10, 2024 | 346.35M |
| April 09, 2024 | 356.89M |
| April 08, 2024 | 351.62M |
| April 05, 2024 | 339.64M |
| Date | Value |
|---|---|
| April 04, 2024 | 339.64M |
| April 03, 2024 | 343.00M |
| April 02, 2024 | 344.91M |
| April 01, 2024 | 383.72M |
| March 28, 2024 | 380.18M |
| March 27, 2024 | 397.42M |
| March 26, 2024 | 382.58M |
| March 25, 2024 | 379.71M |
| March 22, 2024 | 384.02M |
| March 21, 2024 | 335.65M |
| March 20, 2024 | 335.65M |
| March 19, 2024 | 333.74M |
| March 18, 2024 | 327.04M |
| March 15, 2024 | 340.92M |
| March 14, 2024 | 325.12M |
| March 13, 2024 | 321.29M |
| March 12, 2024 | 323.68M |
| March 11, 2024 | 314.11M |
| March 08, 2024 | 313.63M |
| March 07, 2024 | 341.88M |
| March 06, 2024 | 342.36M |
| March 05, 2024 | 336.61M |
| March 04, 2024 | 340.92M |
| March 01, 2024 | 344.75M |
| February 29, 2024 | 322.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
35.88M
Minimum
Dec 27 2022
465.72M
Maximum
May 06 2024
143.51M
Average
107.59M
Median
Market Cap Benchmarks
| AnaptysBio Inc | 665.60M |
| CEL-SCI Corp | 79.89M |
| AIM ImmunoTech Inc | 21.71M |
| IGC Pharma Inc | 33.78M |
| NovaBay Pharmaceuticals Inc | 2.426M |
Market Cap Related Metrics
| PS Ratio | 24.10 |
| Price to Book Value | 2.719 |
| Price | 7.76 |
| Earnings Yield | -23.07% |